vs
HAVERTY FURNITURE COMPANIES INC（HVT）与Ultragenyx Pharmaceutical Inc.（RARE）财务数据对比。点击上方公司名可切换其他公司
Ultragenyx Pharmaceutical Inc.的季度营收约是HAVERTY FURNITURE COMPANIES INC的1.0倍（$207.3M vs $201.9M），HAVERTY FURNITURE COMPANIES INC净利率更高（4.2% vs -62.0%，领先66.2%），Ultragenyx Pharmaceutical Inc.同比增速更快（25.9% vs 9.5%），HAVERTY FURNITURE COMPANIES INC自由现金流更多（$3.0M vs $-100.8M），过去两年Ultragenyx Pharmaceutical Inc.的营收复合增速更高（38.0% vs 4.8%）
该企业原名为国际鞋业公司，1911年由两家鞋企合并成立于美国密苏里州克莱顿，后开展多元化业务并逐步退出制鞋领域，最终更名为家具品牌国际，是美国家居行业知名企业，曾拥有布罗伊希尔等多个知名家具品牌。
Ultragenyx Pharmaceutical Inc.是一家总部位于美国的生物制药企业，专注于研发罕见病和超罕见遗传病的创新治疗方案，这类疾病目前大多无获批疗法，存在大量未被满足的临床需求。公司覆盖生物制剂、小分子药物、基因疗法、反义寡核苷酸及mRNA等多种药物技术平台，研发管线涵盖骨骼、内分泌、代谢、肌肉及中枢神经系统疾病领域。
HVT vs RARE — 直观对比
损益表 — Q4 FY2025 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $201.9M | $207.3M |
| 净利润 | $8.5M | $-128.6M |
| 毛利率 | 60.4% | — |
| 营业利润率 | 5.3% | -54.7% |
| 净利率 | 4.2% | -62.0% |
| 营收同比 | 9.5% | 25.9% |
| 净利润同比 | 4.1% | 3.5% |
| 每股收益（稀释后） | — | $-1.28 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
| Q4 25 | $201.9M | $207.3M | ||
| Q3 25 | $194.5M | $159.9M | ||
| Q2 25 | $181.0M | $166.5M | ||
| Q1 25 | $181.6M | $139.3M | ||
| Q4 24 | $184.4M | $164.6M | ||
| Q3 24 | $175.9M | $139.5M | ||
| Q2 24 | $178.6M | $147.0M | ||
| Q1 24 | $184.0M | $108.8M |
| Q4 25 | $8.5M | $-128.6M | ||
| Q3 25 | $4.7M | $-180.4M | ||
| Q2 25 | $2.7M | $-115.0M | ||
| Q1 25 | $3.8M | $-151.1M | ||
| Q4 24 | $8.2M | $-133.2M | ||
| Q3 24 | $4.9M | $-133.5M | ||
| Q2 24 | $4.4M | $-131.6M | ||
| Q1 24 | $2.4M | $-170.7M |
| Q4 25 | 60.4% | — | ||
| Q3 25 | 60.3% | — | ||
| Q2 25 | 60.8% | — | ||
| Q1 25 | 61.2% | — | ||
| Q4 24 | 61.9% | — | ||
| Q3 24 | 60.2% | — | ||
| Q2 24 | 60.4% | — | ||
| Q1 24 | 60.3% | — |
| Q4 25 | 5.3% | -54.7% | ||
| Q3 25 | 3.3% | -106.9% | ||
| Q2 25 | 2.4% | -64.8% | ||
| Q1 25 | 2.9% | -102.6% | ||
| Q4 24 | 5.2% | -74.3% | ||
| Q3 24 | 3.9% | -94.6% | ||
| Q2 24 | 3.6% | -79.1% | ||
| Q1 24 | 1.7% | -151.9% |
| Q4 25 | 4.2% | -62.0% | ||
| Q3 25 | 2.4% | -112.8% | ||
| Q2 25 | 1.5% | -69.0% | ||
| Q1 25 | 2.1% | -108.5% | ||
| Q4 24 | 4.4% | -80.9% | ||
| Q3 24 | 2.8% | -95.7% | ||
| Q2 24 | 2.5% | -89.5% | ||
| Q1 24 | 1.3% | -156.8% |
| Q4 25 | — | $-1.28 | ||
| Q3 25 | — | $-1.81 | ||
| Q2 25 | — | $-1.17 | ||
| Q1 25 | — | $-1.57 | ||
| Q4 24 | — | $-1.34 | ||
| Q3 24 | — | $-1.40 | ||
| Q2 24 | — | $-1.52 | ||
| Q1 24 | — | $-2.03 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $125.3M | $421.0M |
| 总债务越低越好 | — | — |
| 股东权益账面价值 | $307.9M | $-80.0M |
| 总资产 | $649.1M | $1.5B |
| 负债/权益比越低杠杆越低 | — | — |
8季度趋势，按日历期对齐
| Q4 25 | $125.3M | $421.0M | ||
| Q3 25 | $130.5M | $202.5M | ||
| Q2 25 | $107.4M | $176.3M | ||
| Q1 25 | $111.9M | $127.1M | ||
| Q4 24 | $120.0M | $174.0M | ||
| Q3 24 | $121.2M | $150.6M | ||
| Q2 24 | $109.9M | $480.7M | ||
| Q1 24 | $111.8M | $112.3M |
| Q4 25 | $307.9M | $-80.0M | ||
| Q3 25 | $306.0M | $9.2M | ||
| Q2 25 | $304.9M | $151.3M | ||
| Q1 25 | $305.4M | $144.2M | ||
| Q4 24 | $307.6M | $255.0M | ||
| Q3 24 | $307.8M | $346.8M | ||
| Q2 24 | $307.1M | $432.4M | ||
| Q1 24 | $306.7M | $140.3M |
| Q4 25 | $649.1M | $1.5B | ||
| Q3 25 | $651.7M | $1.2B | ||
| Q2 25 | $642.7M | $1.3B | ||
| Q1 25 | $642.7M | $1.3B | ||
| Q4 24 | $648.7M | $1.5B | ||
| Q3 24 | $659.3M | $1.5B | ||
| Q2 24 | $642.1M | $1.6B | ||
| Q1 24 | $640.5M | $1.3B |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $7.4M | $-99.8M |
| 自由现金流经营现金流 - 资本支出 | $3.0M | $-100.8M |
| 自由现金流率自由现金流/营收 | 1.5% | -48.6% |
| 资本支出强度资本支出/营收 | 2.2% | 0.5% |
| 现金转化率经营现金流/净利润 | 0.86× | — |
| 过去12个月自由现金流最近4个季度 | $33.0M | $-472.0M |
8季度趋势，按日历期对齐
| Q4 25 | $7.4M | $-99.8M | ||
| Q3 25 | $31.9M | $-91.4M | ||
| Q2 25 | $7.2M | $-108.3M | ||
| Q1 25 | $6.2M | $-166.5M | ||
| Q4 24 | $16.9M | $-79.3M | ||
| Q3 24 | $24.4M | $-67.0M | ||
| Q2 24 | $14.4M | $-77.0M | ||
| Q1 24 | $3.1M | $-190.7M |
| Q4 25 | $3.0M | $-100.8M | ||
| Q3 25 | $28.3M | $-92.7M | ||
| Q2 25 | $1.6M | $-110.7M | ||
| Q1 25 | $27.0K | $-167.8M | ||
| Q4 24 | $9.1M | $-79.5M | ||
| Q3 24 | $16.1M | $-68.6M | ||
| Q2 24 | $4.9M | $-79.0M | ||
| Q1 24 | $-3.3M | $-193.9M |
| Q4 25 | 1.5% | -48.6% | ||
| Q3 25 | 14.6% | -58.0% | ||
| Q2 25 | 0.9% | -66.5% | ||
| Q1 25 | 0.0% | -120.5% | ||
| Q4 24 | 4.9% | -48.3% | ||
| Q3 24 | 9.2% | -49.2% | ||
| Q2 24 | 2.7% | -53.7% | ||
| Q1 24 | -1.8% | -178.2% |
| Q4 25 | 2.2% | 0.5% | ||
| Q3 25 | 1.8% | 0.8% | ||
| Q2 25 | 3.1% | 1.5% | ||
| Q1 25 | 3.4% | 1.0% | ||
| Q4 24 | 4.2% | 0.1% | ||
| Q3 24 | 4.7% | 1.2% | ||
| Q2 24 | 5.3% | 1.4% | ||
| Q1 24 | 3.5% | 3.0% |
| Q4 25 | 0.86× | — | ||
| Q3 25 | 6.75× | — | ||
| Q2 25 | 2.69× | — | ||
| Q1 25 | 1.63× | — | ||
| Q4 24 | 2.06× | — | ||
| Q3 24 | 4.96× | — | ||
| Q2 24 | 3.25× | — | ||
| Q1 24 | 1.31× | — |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
HVT
| Upholstery | $91.0M | 45% |
| Bedroom Furniture | $29.2M | 14% |
| Accessories And Other | $28.4M | 14% |
| Dining Room Furniture | $22.8M | 11% |
| Mattresses | $16.1M | 8% |
| Occasional | $14.4M | 7% |
RARE
| Royalty | $105.6M | 51% |
| Products | $101.7M | 49% |
